Cargando…
Acute Pancreatitis Induced by Linagliptin: A Rare but Dangerous Side Effect
Diabetes mellitus type 2 (DMT2) is a highly prevalent disease both in the United States and worldwide. Multiple treatment options are currently available, and several new groups of medications have been introduced over the last couple of decades. One of these groups is dipeptidyl peptidase-4 (DPP-4)...
Autores principales: | Sharko, Artem, Samuel, Shirly, Jain, Nikita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8075763/ https://www.ncbi.nlm.nih.gov/pubmed/33927920 http://dx.doi.org/10.7759/cureus.14104 |
Ejemplares similares
-
Acute Pancreatitis: A Possible Side Effect of COVID-19 Vaccine
por: Parkash, Om, et al.
Publicado: (2021) -
Mild Pancreatitis Induced by Linagliptin Revealed by a Medication Review
por: Gidda, Harish, et al.
Publicado: (2023) -
Effects of Linagliptin and Pioglitazone on Fracture Healing in an Experimental Type 2 Diabetes Rat Model
por: Mraja, Hamisi M, et al.
Publicado: (2022) -
Adverse Side Effects: Empagliflozin-Related Acute Pancreatitis Case Report
por: Zeidan, Bassem S, et al.
Publicado: (2020) -
A Rare Case of Statin-Induced Diplopia: An Often-Overlooked but Reported Side Effect
por: Abdelmasih, Randa, et al.
Publicado: (2021)